CAVA Group is recommended at Piper Sandler after recent stumble
Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at ...
Hosted on MSN23m
Piper Sandler Initiates Coverage of Avalo Therapeutics (AVTX) with Overweight Recommendation
Fintel reports that on February 28, 2025, Piper Sandler initiated coverage of Avalo Therapeutics (NasdaqCM:AVTX) with a ...
Piper Sandler Boosts Couchbase (NASDAQ:BASE) Price Target to $22.00
Couchbase (NASDAQ:BASE – Get Free Report) had its target price upped by research analysts at Piper Sandler from $21.00 to $22 ...
Kymera Therapeutics (KYMR) Receives a Buy from Piper Sandler
Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Kymera Therapeutics (KYMR – Research Report) today and set a price target of ...
Masimo (NASDAQ:MASI) Price Target Raised to $215.00
Masimo (NASDAQ:MASI – Get Free Report) had its price objective upped by equities researchers at Piper Sandler from $210.00 to $215.00 in a report released on Wednesday,Benzinga reports. The brokerage ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Iovance Biotherapeutics (IOVA), Xencor (XNCR) and Merus (MRUS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Iovance Biotherapeutics (IOVA – Research ...
Finbold | Finance in Bold17h
Here’s how analysts reacted to Nvidia’s (NVDA) earnings report
NVDA stock price reacts to Nvidia's latest earnings, with analysts weighing in on AI demand, Blackwell GPU adoption, and ...